// App-Quantinova.ai

: Late Breaking Abstract - Characteristics and treatment of patients with comorbid COPD and heart failure

Researchers

Presenter

  • David Price

Principal Investigators

  • Ronan Ryan

  • Robert Fogel

  • Hui Cao

  • Janwillem W.H. Kocks

  • Piergiuseppe Agostoni

  • Chin Kook Rhee

  • John R. Hurst

  • Rupert Jones

  • Konstantinos Kostikas

Medical Centers

  • Observational and Pragmatic Research Institute, Singapore, Singapore,

  • Novartis Pharmaceuticals Corporation East Hanover NJ United States

  • Centro Cardiologico Monzino, IRCCS, Department of Clinical Sciences and Community Health, Cardiovascular Section, Università degli Studi di Milano, Milan, Italy

  • Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Yeouido St. Mary`s Hospital, The Catholic University of Korea, Seoul, Korea, Republic of.

  • UCL Respiratory, University College London, London, United Kingdom

  • Novartis AG, Basel, Switzerland

Locations

  • Singapore

  • United States

  • Italy

  • Republic of South Korea

  • United Kingdom

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Congestive heart failure

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved